CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.07
−0.99%Leverage
- Debt / equity
- 0.76x
- Net debt / equity
- -0.40x
- Debt / assets
- 0.37x
- Debt / EBITDA
- 2.62x
- Net debt / EBITDA
- -1.38x
Liquidity & coverage
- Current ratio
- 5.53x
- Quick ratio
- 4.88x
- Cash ratio
- 4.14x
- Interest coverage
- 3.27x
- EBITDA / interest
- 3.68x
- Working capital
- $866.4M
Cash & dividend
- FCF / debt
- 0.32x
- Cash flow / debt
- 0.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026